Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
bene-Arzneimittel
bene-Arzneimittel
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Elmiron
Pentosan polysulfate
2017-06-02
Interstitial cystitis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sodium chloride
dermatomyositis
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
diabetes mellitus
,
type 1 diabetes mellitus
,
leukemia
,
myelodysplastic syndromes
,
non-hodgkin lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
hodgkin disease
,
chronic kidney failure
,
lupus nephritis
,
nephritis
,
rheumatoid arthritis
,
psoriasis
,
arthritis
,
colorectal neoplasms
,
covid-19
,
psoriatic arthritis
,
breast neoplasms
,
hematologic neoplasms
,
bone fractures
,
graves ophthalmopathy
,
eye diseases
,
thyroid diseases
,
neoplasm metastasis
,
chronic renal insufficiency
,
kidney diseases
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
cardiovascular diseases
,
atherosclerosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use